Munich - Delayed Quote • EUR CytoDyn Inc (296.MU) Follow 0.1400 0.0000 (0.00%) At close: April 25 at 8:11 AM GMT+2 Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for 296.MU 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: 296.MU View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations CytoDyn Announces FDA Has Lifted Clinical Hold CytoDyn Announces Submission of Clinical Protocol to FDA and Initiation of Pre-Clinical Study in Glioblastoma CytoDyn Appoints Jacob Lalezari M.D. as CEO, Mitchell Cohen as Interim CFO CytoDyn Announces Webcast to Provide Company Update CytoDyn Appoints Jacob Lalezari M.D. as Interim CEO November 2023 Letter to Shareholders CytoDyn Announces Company Updates and Investment Community Update Webcast CytoDyn Announces President Takes Medical Leave of Absence
